Developmental Research Program
Director: Martin E. Fernandez-Zapico, M.D.
The goal of the Developmental Research Program in the Mayo Clinic SPORE in Pancreatic Cancer is to support innovative, scientifically sound research projects from which findings can be translated into clinically relevant applications that will impact the screening, diagnosis and management of pancreatic cancer.
The Developmental Research Program uses both SPORE grant and institutional resources to fund two or three projects annually, with the possibility of a second year of support based on progress.
The Mayo Clinic SPORE in Pancreatic Cancer calls for applications annually. The SPORE's Scientific Advisory Committee and other experienced investigators, including RAPPORT advocates, formally peer review submissions for the awards.
Criteria for awards include scientific merit, originality, qualifications and interactions of key personnel, and translational potential.
Winning projects are expected to generate new hypotheses that can be tested in larger scale research projects or clinical trials that impact pancreatic cancer. SPORE leadership encourages and helps the investigators use the data generated by these projects to design either R01-type grants or similar extramural proposals.